On March 9, Xie Bing, senior vice chairman of CP Group and founder of "China Biopharmaceuticals", and his delegation visited Luoyang Modern Biotechnology Research Institute Co., Ltd. (hereinafter referred to as "Modern Bio").

Participants also included Sui Xiaodong, Vice President of New Business Department of CP Pharmaceutical Group, Chen Guang, Vice President of New Business Department of CP Pharmaceutical Group, Lin Lijia, Secretary to the Chairman of CP Pharmaceutical Group, Li Fuqiang, Chairman of CP Jianlong Co., Ltd., and Chief Engineer of CP Energy Co., Ltd. Wang Chuang, deputy general manager Tian Lei of CP Jianlong, and Dong Ying, chief financial officer of CP Jianlong. Wei Bin, Director of the Luoyang Municipal Industry and Information Technology Bureau, Yu Litao, Deputy Director of the Luoyang Municipal Industry and Information Technology Bureau, Wu Tao, Deputy Secretary of the Luolong District Party Committee and Director of Luoyang Economic Development Zone, Zhang Hui, Director of the Luoyang District Industry and Information Technology Bureau, and other leaders accompanied the event.

Mr. Wang Shanpu, Chairman of Modern Biotechnology, and Mr. Xie Bing had an in-depth communication.